For instance, some studies suggest that the prevalence of CLS-B may be low among women without BBD or breast cancer (e.g., 3% and 18% in two samples of KTB normal breast tissue donors [84,85] and 2% in a sample of women who received reduction mammoplasty [86]). The gene discussed is PPIB; the disease is breast cancer.